Arkios BioDevelopment International (Arkios) is a biopharmaceutical clinical research organization, engaged in providing contract research services to promising technology companies developing novel drugs, biologics, diagnostics and medical devices. In addition, Arkios is also engaged in the design and management of clinical development of promising technologies in the biopharmaceutical and device areas during product registration. Arkios serves in two functional fields including: early stage product development services and phase II-IV clinical trial management. The services provided by Arkios include, strategic planning, clinical operations and regulatory affairs and data management and biostatistics. Arkios is specialized in the areas including: dermatology including wound healing, oncology, gene therapy, plasma products, vaccines, infectious diseases, diabetes, CNS and as well as in diagnostics and medical devices. The company is headquartered at Virginia Beach in Virginia, the US.

Street: 
421 S. Lynnhaven Road
City: 
Virginia Beach
Postcode: 
23452
Federal State : 
United States
WebSite: 
www.arkios.com
Fax: 
1-757-6312115

Company Index Score

Current Index Score Historical Index Score
  • Arkios BioDevelopment International currently scores 50 % in the index.
  • Arkios BioDevelopment International is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Arkios BioDevelopment International is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets